OpenAlex
PricingAboutJobs
Log inGet started
Work

Multicenter phase II trial of pembrolizumab (pembro) in previously-treated metastatic esophageal cancer.

HTML

Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2018.36.15_suppl.e16072
Authors: Peter C. Enzinger, Nadine Jackson McCleary, Nora Horick, James M. Cleary, Douglas Adam Rubinson, Bridget Fitzpatrick, Christopher Graham, Jeffrey W. Clark, Anuj K. Patel, Eirini Pectasides, Kimberly Perez, Matthew B. Yurgelun, Christopher G. Azzoli, Andrea Catherine Enzinger, Justin F. Gainor, Benjamin L. Schlechter, Jeffrey A. Meyerhardt, Kimmie Ng, Adam Joel Bass, Charles S. Fuchs
Institutions: Dana-Farber Cancer Institute, Massachusetts General Hospital, Beth Israel Deaconess Medical Center, Yale New Haven Hospital, Yale New Haven Health System, Smilow Cancer Hospital
Language: English

Topic: Esophageal Cancer Research and Treatment
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2890079918
Cites:
Cited by: 1
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms